Connect with us

Health

Botox Competitor Approved By FDA

Avatar of Salman Ahmad

Published

on

Botox Competitor Approved By FDA

(CTN News) _ FDA is expected that an alternative to Botox will soon be available to those who wish to keep wrinkles at bay now that the FDA has approved the first competitor Botox in decades.

The drug Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is injected along worry lines.

About 80% of users see no or mild facial lines four months after injection, which lasts longer than Botox. The treatment lasted six months for half of users, the company said.

Dr. Balaji Prasad, an analyst with Barclays Investment Bank covering specialty pharmaceuticals, says users don’t have to go every three months.

In a world where time is of the essence, a long-lasting product is extremely useful.”

A neuromuscular blocking agent and botulinum toxin, like Abbvie’s Botox, the new drug enters the $3 billion facial injection drug market.

Revance CEO Mark Foley told the Times that the new technology opens up therapeutic possibilities.

There are also huge medical opportunities with migraines, cervical dystonia, overactive bladder, etc.

The company has tested these other medical issues. Instead of creating a needle-free product, it discovered how to stabilize it using peptide technology.

Typically, human serum or animal protein is used.

In 2010, the FDA approved Botox as a treatment for chronic migraines.

About 2% of people in the Revance studies experienced drooping eyelids, and about 6% had headaches.

In addition to general muscle weakness and breathing difficulties, toxins-based treatment can have other side effects, the FDA cautioned. Daxxify study participants showed none.

Due to pandemic restrictions, Revance’s plans have been pushed back to November 2020.

The company’s working cell bank, which contains the drug’s active ingredient, was found to have quality control problems in June 2021. These concerns have been resolved.

Is the FDA only in the US?

The FDA has a number of field offices across the United States, in addition to international locations in China, India, Europe, the Middle East, and Latin America.
Child agencies: Center for Biologics Evaluation …
Preceding agencies: Food, Drug, and Insectici…
Annual budget: US$6.5 billion (2022)
Jurisdiction: Federal government of the United 

New York Declares A State Of Emergency Over Polio

Thai Public Health Ministry to Procure 3 Million Doses Of Pfizer Vaccine For Children

Monkeypox 1st Case Reported In Jordan

Continue Reading

CTN News App

CTN News App

Recent News

BUY FC 24 COINS

compras monedas fc 24

Volunteering at Soi Dog

Find a Job

Jooble jobs

Free ibomma Movies